临床挑战:肾上腺肿物的内分泌与影像学评估
肾上腺意外瘤在腹部解剖影像检查中占3%-4%,评估需结合解剖与功能影像及生化检查。多数患者先经CT或MRI评估,若无法明确病因,应在激素筛查后使用分子影像技术。本文综述成熟与新兴核医学影像模式及其在不同临床场景中的应用。
要点
- 肾上腺意外瘤在腹部影像检查中占3%-4%,评估常见。
- CT或MRI可部分表征肿瘤并纵向随访排除恶性行为。
- CT或MRI无法明确病因者,激素筛查后可行分子影像。
核心结论
- 解剖与功能影像结合生化评估对肾上腺病变亚型诊断至关重要。
- CT或MRI无法表征肾上腺肿瘤发病机制时,激素筛查后应使用专门分子影像技术。
研究设计与样本
- 综述,强调成熟与新兴核医学影像模式并描述其在不同临床场景中的应用。
主要发现
- 肾上腺意外瘤在腹部解剖影像检查患者中报告率为3%-4%。
- 肾上腺肿物可由良性皮质与髓质肿瘤、恶性原发或继发肿瘤、囊肿、增生、出血或罕见的感染/炎症过程引起。
- 功能性肿瘤通常激素产生增加但较少见,部分肿瘤无论功能状态如何均可能具侵袭性。
临床怎么用
- 多数患者初始评估用CT或MRI以部分表征肿瘤并通过纵向随访无肿瘤生长排除恶性行为。
- CT或MRI无法明确肾上腺肿瘤发病机制者,应在激素筛查后行专门分子影像技术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Incidentalomas are reported in 3%-4% of patients who undergo abdominal anatomic imaging, making adrenal mass evaluation a common occurrence. An adrenal mass can be caused by a variety of pathologies, such as benign cortical and medullary tumors, malignant tumors (primary or secondary), cysts, hyperplasia, hemorrhage, or more rarely infection/inflammation processes. Functioning tumors usually have increased hormonal production but they are less common. Regardless of their functional status, some tumors have the potential to behave aggressively. Anatomic and functional imaging together with biologic evaluation play a vital role in adrenal pathology subtyping. Most patients are initially evaluated by CT or MRI, which allows for tumor characterization (to a certain extent) and can rule out malignant behavior based on the absence of tumor growth during longitudinal follow-up. In the remaining patients for whom CT or MRI fail to characterize the pathogenesis of adrenal tumors, the use of specialized molecular imaging techniques should be performed after hormonal screening. This review emphasizes well-established and emerging nuclear medicine imaging modalities and describes their use across various clinical scenarios.
引用
- Sundin A, Hindié E, Avram AM, et al. A Clinical Challenge: Endocrine and Imaging Investigations of Adrenal Masses. J Nucl Med. 2021. PMID: 34230070. doi:10.2967/jnumed.120.246066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。